An Early and Rare Second Malignancy in A Treated Glioblastoma Multiforme: Is It Radiation or Temozolomide?

• Published in: Journal of clinical and diagnostic research Vol. 9; no. 4; pp. TD05 - TD07
• Main Authors: Goyal, Shina, Singh, Rabi Raja, Balukrishna, Sasidharan, Bindra, Mandeep, Backianathan, Selvamani
• Format: Journal Article
• Language: English
• Published: Delhi, India JCDR Research and Publications (P) Limited 01.04.2015
• Subjects: Radiology Section
• ISSN: 2249-782X; 0973-709X
• DOI: 10.7860/JCDR/2015/13588.5833

Glioblastoma Multiforme (GBM) is a high-grade brain tumour with the most dismal prognosis. There are very few reports on second malignancies occurring in GBM patients, as the survival has been short. Second malignancies have been reported after treatment of malignancies with radiation therapy and chemotherapy especially after 5 to 10 y of treatment. Here in, we present a very unique case where a patient succumbed to sinonasal carcinoma occurring one and half years after treatment of GBM. A 17-year-old boy was diagnosed to have GBM and underwent surgery followed by chemoradiation and adjuvant chemotherapy with Temozolamide. He presented with undifferentiated sinonasal carcinoma, in the sinonasal region outside the radiation field within two years of treatment. Here we discuss the histology and possible chances of it being a second malignancy.